Analysts who follow G1 Therapeutics Inc (GTHX) on average expect it to increase 358.05% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns GTHX an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With G1 Therapeutics Inc Stock Today?
G1 Therapeutics Inc (GTHX) stock has risen 1.75% while the S&P 500 has fallen -0.08% as of 1:13 PM on Tuesday, Oct 27. GTHX has risen $0.20 from the previous closing price of $11.71 on volume of 314,897 shares. Over the past year the S&P 500 is higher by 11.81% while GTHX has fallen -45.57%. GTHX lost -$3.45 per share the over the last 12 months.
Click Here to get the full report on G1 Therapeutics Inc (GTHX) Stock.
